Results showed that ZNF662 promoter methylation status was detected at a high level in breast tumor tissues, and compared with paired adjacent breast tissues, ZNF662 promoter methylation status was significantly higher in breast cancer tissues (Fig. 2A+B). Here, ZNF662 is linked to breast carcinoma.